{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:20:12Z","timestamp":1790281212508,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T00:00:00Z","timestamp":1398297600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2051-5960-2-48","type":"journal-article","created":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T05:07:12Z","timestamp":1398316032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury"],"prefix":"10.1186","volume":"2","author":[{"given":"Nithi","family":"Asavapanumas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AS","family":"Verkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,24]]},"reference":[{"issue":"8","key":"120_CR1","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1136\/jnnp-2012-302310","volume":"84","author":"A Jacob","year":"2013","unstructured":"Jacob A, McKeon A, Nakashima I, Sato DK, Elsone L, Fujihara K, De Seze J: Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders. J Neurol Neurosurg Psychiatry 2013, 84(8):922\u2013930. doi:10.1136\/jnnp-2012\u2013302310","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"120_CR2","first-page":"202","volume":"4","author":"S Jarius","year":"2008","unstructured":"Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B: Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 2008, 4(4):202\u2013214. doi:10.1038\/ncpneuro0764","journal-title":"Nat Clin Pract Neurol"},{"issue":"9","key":"120_CR3","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG: The spectrum of neuromyelitis optica. Lancet Neurol 2007, 6(9):805\u2013815. doi:S1474\u20134422(07)70216\u20138 10.1016\/S1474-4422(07)70216-8","journal-title":"Lancet Neurol"},{"issue":"7","key":"120_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","volume":"6","author":"S Jarius","year":"2010","unstructured":"Jarius S, Wildemann B: AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance. Nat Rev Neurol 2010, 6(7):383\u2013392. doi:10.1038\/nrneurol.2010.72 10.1038\/nrneurol.2010.72","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"120_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR: IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202(4):473\u2013477. doi:jem.20050304 10.1084\/jem.20050304","journal-title":"J Exp Med"},{"issue":"4","key":"120_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrn3468","volume":"14","author":"MC Papadopoulos","year":"2013","unstructured":"Papadopoulos MC, Verkman AS: Aquaporin water channels in the nervous system. Nat Rev Neurosci 2013, 14(4):265\u2013277. doi:10.1038\/nrn3468 10.1038\/nrn3468","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"120_CR7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","volume":"17","author":"S Nielsen","year":"1997","unstructured":"Nielsen S, Nagelhus EA, Amiry-Moghaddam M, Bourque C, Agre P, Ottersen OP: Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 1997, 17(1):171\u2013180.","journal-title":"J Neurosci"},{"issue":"10","key":"120_CR8","doi-asserted-by":"publisher","first-page":"4328","DOI":"10.1073\/pnas.92.10.4328","volume":"92","author":"A Frigeri","year":"1995","unstructured":"Frigeri A, Gropper MA, Turck CW, Verkman AS: Immunolocalization of the mercurial-insensitive water channel and glycerol intrinsic protein in epithelial cell plasma membranes. Proc Natl Acad Sci U S A 1995, 92(10):4328\u20134331. 10.1073\/pnas.92.10.4328","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 9","key":"120_CR9","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1242\/jcs.108.9.2993","volume":"108","author":"A Frigeri","year":"1995","unstructured":"Frigeri A, Gropper MA, Umenishi F, Kawashima M, Brown D, Verkman AS: Localization of MIWC and GLIP water channel homologs in neuromuscular, epithelial and glandular tissues. J Cell Sci 1995, 108(Pt 9):2993\u20133002.","journal-title":"J Cell Sci"},{"issue":"6","key":"120_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","volume":"11","author":"MC Papadopoulos","year":"2012","unstructured":"Papadopoulos MC, Verkman AS: Aquaporin 4 and neuromyelitis optica. Lancet Neurol 2012, 11(6):535\u2013544. doi:10.1016\/S1474\u20134422(12)70133\u20133 10.1016\/S1474-4422(12)70133-3","journal-title":"Lancet Neurol"},{"issue":"Pt 5","key":"120_CR11","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF: Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007, 130(Pt 5):1194\u20131205. doi:awl371","journal-title":"Brain"},{"issue":"5","key":"120_CR12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1177\/1352458506070145","volume":"13","author":"GJ Hengstman","year":"2007","unstructured":"Hengstman GJ, Wesseling P, Frenken CW, Jongen PJ: Neuromyelitis optica with clinical and histopathological involvement of the brain. Mult Scler 2007, 13(5):679\u2013682. doi:1352458506070145 10.1177\/1352458506070145","journal-title":"Mult Scler"},{"issue":"1\u20132","key":"120_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jns.2011.08.043","volume":"311","author":"J Kira","year":"2011","unstructured":"Kira J: Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: astrocytopathy as a common denominator in demyelinating disorders. J Neurol Sci 2011, 311(1\u20132):69\u201377. doi:10.1016\/j.jns.2011.08.043","journal-title":"J Neurol Sci"},{"issue":"Pt 5","key":"120_CR14","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/brain\/awm047","volume":"130","author":"T Misu","year":"2007","unstructured":"Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y: Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007, 130(Pt 5):1224\u20131234. doi:awm047","journal-title":"Brain"},{"issue":"Pt 7","key":"120_CR15","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/brain\/awf151","volume":"125","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H: A role for humoral mechanisms in the pathogenesis of Devic\u2019s neuromyelitis optica. Brain 2002, 125(Pt 7):1450\u20131461.","journal-title":"Brain"},{"issue":"5","key":"120_CR16","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00401-013-1172-z","volume":"126","author":"J Ratelade","year":"2013","unstructured":"Ratelade J, Asavapanumas N, Ritchie AM, Wemlinger S, Bennett JL, Verkman AS: Involvement of antibody-dependent cell-mediated cytotoxicity in inflammatory demyelination in a mouse model of neuromyelitis optica. Acta Neuropathol 2013, 126(5):699\u2013709. doi:10.1007\/s00401\u2013013\u20131172-z 10.1007\/s00401-013-1172-z","journal-title":"Acta Neuropathol"},{"issue":"1","key":"120_CR17","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/2051-5960-1-85","volume":"1","author":"M Pohl","year":"2013","unstructured":"Pohl M, Kawakami N, Kitic M, Bauer J, Martins R, Fischer MT, Machado-Santos J, Mader S, Ellwart JW, Misu T, Fujihara K, Wekerle H, Reindl M, Lassmann H, Bradl M: T cell-activation in neuromyelitis optica lesions plays a role in their formation. Acta Neuropathol Commun 2013, 1(1):85. doi:10.1186\/2051\u20135960\u20131-85 10.1186\/2051-5960-1-85","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"120_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2051-5960-1-5","volume":"1","author":"M Kitic","year":"2013","unstructured":"Kitic M, Hochmeister S, Wimmer I, Bauer J, Misu T, Mader S, Reindl M, Fujihara K, Lassmann H, Bradl M: Intrastriatal injection of interleukin-1 beta triggers the formation of neuromyelitis optica-like lesions in NMO-IgG seropositive rats. Acta Neuropathol Commun 2013, 1(1):5. doi:10.1186\/2051\u20135960\u20131-5 10.1186\/2051-5960-1-5","journal-title":"Acta Neuropathol Commun"},{"issue":"Pt 2","key":"120_CR19","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S Saadoun","year":"2010","unstructured":"Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC: Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010, 133(Pt 2):349\u2013361. doi:10.1093\/brain\/awp309","journal-title":"Brain"},{"issue":"4","key":"120_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.msard.2012.06.003","volume":"1","author":"MV Jones","year":"2012","unstructured":"Jones MV, Collongues N, De Seze J, Kinoshita M, Nakatsuji Y, Levy M: Review of animal models of neuromyelitis optica. Mult Scler Relat Disord 2012, 1(4):174\u2013179. doi:10.1016\/j.msard.2012.06.003 10.1016\/j.msard.2012.06.003","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"120_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/bpa.12098","volume":"24","author":"M Bradl","year":"2014","unstructured":"Bradl M, Lassmann H: Experimental models of neuromyelitis optica. Brain Pathol 2014, 24(1):74\u201382. doi:10.1111\/bpa.12098 10.1111\/bpa.12098","journal-title":"Brain Pathol"},{"issue":"5","key":"120_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"JL Bennett","year":"2009","unstructured":"Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, Glogowska M, Case D, Antel JP, Owens GP, Gilden D, Nessler S, Stadelmann C, Hemmer B: Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009, 66(5):617\u2013629. doi:10.1002\/ana.21802 10.1002\/ana.21802","journal-title":"Ann Neurol"},{"issue":"5","key":"120_CR23","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/ana.21837","volume":"66","author":"M Bradl","year":"2009","unstructured":"Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, Adzemovic M, Bauer J, Berger T, Fujihara K, Itoyama Y, Lassmann H: Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009, 66(5):630\u2013643. doi:10.1002\/ana.21837 10.1002\/ana.21837","journal-title":"Ann Neurol"},{"issue":"4","key":"120_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bbrc.2009.06.085","volume":"386","author":"M Kinoshita","year":"2009","unstructured":"Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, Kumanogoh A, Kajiyama K, Yoshikawa H, Sakoda S: Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun 2009, 386(4):623\u2013627. doi:10.1016\/j.bbrc.2009.06.085 10.1016\/j.bbrc.2009.06.085","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"120_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbrc.2010.02.157","volume":"394","author":"M Kinoshita","year":"2010","unstructured":"Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, Kumanogoh A, Kajiyama K, Yoshikawa H, Sakoda S: Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells. Biochem Biophys Res Commun 2010, 394(1):205\u2013210. doi:10.1016\/j.bbrc.2010.02.157 10.1016\/j.bbrc.2010.02.157","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"120_CR26","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00401-012-0986-4","volume":"123","author":"J Ratelade","year":"2012","unstructured":"Ratelade J, Zhang H, Saadoun S, Bennett JL, Papadopoulos MC, Verkman AS: Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss. Acta Neuropathol 2012, 123(6):861\u2013872. doi:10.1007\/s00401\u2013012\u20130986\u20134 10.1007\/s00401-012-0986-4","journal-title":"Acta Neuropathol"},{"issue":"3","key":"120_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ana.22686","volume":"71","author":"S Saadoun","year":"2012","unstructured":"Saadoun S, Waters P, MacDonald C, Bell BA, Vincent A, Verkman AS, Papadopoulos MC: Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain. Ann Neurol 2012, 71(3):323\u2013333. doi:10.1002\/ana.22686 10.1002\/ana.22686","journal-title":"Ann Neurol"},{"issue":"6","key":"120_CR28","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/ana.22551","volume":"70","author":"H Zhang","year":"2011","unstructured":"Zhang H, Bennett JL, Verkman AS: Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. Ann Neurol 2011, 70(6):943\u2013954. doi:10.1002\/ana.22551 10.1002\/ana.22551","journal-title":"Ann Neurol"},{"issue":"5","key":"120_CR29","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1172\/JCI67554","volume":"123","author":"H Zhang","year":"2013","unstructured":"Zhang H, Verkman AS: Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica. J Clin Invest 2013, 123(5):2306\u20132316. doi:10.1172\/JCI67554 10.1172\/JCI67554","journal-title":"J Clin Invest"},{"key":"120_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1742-2094-11-16","volume":"11","author":"N Asavapanumas","year":"2014","unstructured":"Asavapanumas N, Ratelade J, Papadopoulos MC, Bennett JL, Levin MH, Verkman AS: Experimental mouse model of optic neuritis with inflammatory demyelination produced by passive transfer of neuromyelitis optica-immunoglobulin G. J Neuroinflammation 2014, 11: 16. doi:10.1186\/1742\u20132094\u201311\u201316 10.1186\/1742-2094-11-16","journal-title":"J Neuroinflammation"},{"key":"120_CR31","volume-title":"J Autoimmun","author":"H Zhang","year":"2014","unstructured":"Zhang H, Verkman AS: Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59. J Autoimmun 2014. doi: 10.1016\/j.jaut.2014.02.011. [Epub ahead of print]"},{"key":"120_CR32","volume-title":"Cancer Immunol Immunother","author":"I Bergman","year":"2000","unstructured":"Bergman I, Basse PH, Barmada MA, Griffin JA, Cheung NK: Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors. Cancer Immunol Immunother 2000., 49:"},{"issue":"4","key":"120_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00401-013-1204-8","volume":"127","author":"N Asavapanumas","year":"2014","unstructured":"Asavapanumas N, Ratelade J, Verkman AS: Unique neuromyelitis optica pathology produced in naive rats by intracerebral administration of NMO-IgG. Acta Neuropathol 2014, 127(4):539\u2013551. doi:10.1007\/s00401\u2013013\u20131204\u20138 10.1007\/s00401-013-1204-8","journal-title":"Acta Neuropathol"},{"issue":"3","key":"120_CR34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/ana.22657","volume":"71","author":"L Tradtrantip","year":"2012","unstructured":"Tradtrantip L, Zhang H, Saadoun S, Phuan PW, Lam C, Papadopoulos MC, Bennett JL, Verkman AS: Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol 2012, 71(3):314\u2013322. doi:10.1002\/ana.22657 10.1002\/ana.22657","journal-title":"Ann Neurol"},{"issue":"1","key":"120_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/ana.23741","volume":"73","author":"L Tradtrantip","year":"2013","unstructured":"Tradtrantip L, Ratelade J, Zhang H, Verkman AS: Enzymatic deglycosylation converts pathogenic neuromyelitis optica anti-aquaporin-4 immunoglobulin G into therapeutic antibody. Ann Neurol 2013, 73(1):77\u201385. doi:10.1002\/ana.23741 10.1002\/ana.23741","journal-title":"Ann Neurol"},{"issue":"6","key":"120_CR36","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1124\/mol.113.086470","volume":"83","author":"L Tradtrantip","year":"2013","unstructured":"Tradtrantip L, Asavapanumas N, Verkman AS: Therapeutic cleavage of anti-aquaporin-4 autoantibody in neuromyelitis optica by an IgG-selective proteinase. Mol Pharmacol 2013, 83(6):1268\u20131275. doi:10.1124\/mol.113.086470 10.1124\/mol.113.086470","journal-title":"Mol Pharmacol"},{"issue":"6","key":"120_CR37","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00401-013-1128-3","volume":"125","author":"PW Phuan","year":"2013","unstructured":"Phuan PW, Zhang H, Asavapanumas N, Leviten M, Rosenthal A, Tradtrantip L, Verkman AS: C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica. Acta Neuropathol 2013, 125(6):829\u2013840. doi:10.1007\/s00401\u2013013\u20131128\u20133 10.1007\/s00401-013-1128-3","journal-title":"Acta Neuropathol"},{"issue":"6","key":"120_CR38","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S1474-4422(13)70076-0","volume":"12","author":"SJ Pittock","year":"2013","unstructured":"Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O\u2019Toole O, Wingerchuk DM: Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol 2013, 12(6):554\u2013562. doi:10.1016\/S1474\u20134422(13)70076\u20130 10.1016\/S1474-4422(13)70076-0","journal-title":"Lancet Neurol"},{"issue":"18","key":"120_CR39","doi-asserted-by":"publisher","first-page":"16516","DOI":"10.1074\/jbc.M111.227298","volume":"286","author":"JM Crane","year":"2011","unstructured":"Crane JM, Lam C, Rossi A, Gupta T, Bennett JL, Verkman AS: Binding affinity and specificity of neuromyelitis optica autoantibodies to aquaporin-4\u00a0M1\/M23 isoforms and orthogonal arrays. J Biol Chem 2011, 286(18):16516\u201316524. doi:10.1074\/jbc.M111.227298 10.1074\/jbc.M111.227298","journal-title":"J Biol Chem"},{"issue":"17","key":"120_CR40","doi-asserted-by":"publisher","first-page":"13829","DOI":"10.1074\/jbc.M112.344325","volume":"287","author":"PW Phuan","year":"2012","unstructured":"Phuan PW, Ratelade J, Rossi A, Tradtrantip L, Verkman AS: Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays. J Biol Chem 2012, 287(17):13829\u201313839. doi:10.1074\/jbc.M112.344325 10.1074\/jbc.M112.344325","journal-title":"J Biol Chem"},{"issue":"1","key":"120_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.pain.2007.11.005","volume":"137","author":"ME Levin","year":"2008","unstructured":"Levin ME, Jin JG, Ji RR, Tong J, Pomonis JD, Lavery DJ, Miller SW, Chiang LW: Complement activation in the peripheral nervous system following the spinal nerve ligation model of neuropathic pain. Pain 2008, 137(1):182\u2013201. doi:S0304\u20133959(07)00672\u20130 10.1016\/j.pain.2007.11.005","journal-title":"Pain"},{"issue":"7","key":"120_CR42","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.toxicon.2010.04.007","volume":"56","author":"CW Vogel","year":"2010","unstructured":"Vogel CW, Fritzinger DC: Cobra venom factor: Structure, function, and humanization for therapeutic complement depletion. Toxicon 2010, 56(7):1198\u20131222. doi:10.1016\/j.toxicon.2010.04.007 10.1016\/j.toxicon.2010.04.007","journal-title":"Toxicon"},{"issue":"11","key":"120_CR43","doi-asserted-by":"publisher","first-page":"e27412","DOI":"10.1371\/journal.pone.0027412","volume":"6","author":"J Ratelade","year":"2011","unstructured":"Ratelade J, Bennett JL, Verkman AS: Intravenous neuromyelitis optica autoantibody in mice targets aquaporin-4 in peripheral organs and area postrema. PLoS One 2011, 6(11):e27412. doi:10.1371\/journal.pone.0027412 10.1371\/journal.pone.0027412","journal-title":"PLoS One"},{"issue":"10","key":"120_CR44","first-page":"1247","volume":"79","author":"SK Singhrao","year":"1999","unstructured":"Singhrao SK, Neal JW, Rushmere NK, Morgan BP, Gasque P: Differential expression of individual complement regulators in the brain and choroid plexus. Lab Invest 1999, 79(10):1247\u20131259.","journal-title":"Lab Invest"},{"issue":"6","key":"120_CR45","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.4049\/jimmunol.173.6.3684","volume":"173","author":"S Baalasubramanian","year":"2004","unstructured":"Baalasubramanian S, Harris CL, Donev RM, Mizuno M, Omidvar N, Song WC, Morgan BP: CD59a is the primary regulator of membrane attack complex assembly in the mouse. J Immunol 2004, 173(6):3684\u20133692. doi:173\/6\/3684 10.4049\/jimmunol.173.6.3684","journal-title":"J Immunol"},{"issue":"4","key":"120_CR46","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.4049\/jimmunol.174.4.2353","volume":"174","author":"J Van Beek","year":"2005","unstructured":"Van Beek J, Van Meurs M, t Hart BA, Brok HP, Neal JW, Chatagner A, Harris CL, Omidvar N, Morgan BP, Laman JD, Gasque P: Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation. J Immunol 2005, 174(4):2353\u20132365. doi:174\/4\/2353 10.4049\/jimmunol.174.4.2353","journal-title":"J Immunol"},{"issue":"4","key":"120_CR47","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1136\/gut.2003.026773","volume":"53","author":"KA Gelderman","year":"2004","unstructured":"Gelderman KA, Zijlmans HJ, Vonk MJ, Gorter A: CD55 expression patterns on intestinal neuronal tissue are divergent from the brain. Gut 2004, 53(4):507\u2013513. 10.1136\/gut.2003.026773","journal-title":"Gut"},{"issue":"22","key":"120_CR48","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1212\/WNL.0b013e3181a82621","volume":"72","author":"S Nishiyama","year":"2009","unstructured":"Nishiyama S, Ito T, Misu T, Takahashi T, Kikuchi A, Suzuki N, Jin K, Aoki M, Fujihara K, Itoyama Y: A case of NMO seropositive for aquaporin-4 antibody more than 10\u00a0years before onset. Neurology 2009, 72(22):1960\u20131961. doi:10.1212\/WNL.0b013e3181a82621 10.1212\/WNL.0b013e3181a82621","journal-title":"Neurology"},{"issue":"5","key":"120_CR49","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1096\/fj.11-201608","volume":"26","author":"L Tradtrantip","year":"2012","unstructured":"Tradtrantip L, Zhang H, Anderson MO, Saadoun S, Phuan PW, Papadopoulos MC, Bennett JL, Verkman AS: Small-molecule inhibitors of NMO-IgG binding to aquaporin-4 reduce astrocyte cytotoxicity in neuromyelitis optica. FASEB J 2012, 26(5):2197\u20132208. doi:10.1096\/fj.11\u2013201608 10.1096\/fj.11-201608","journal-title":"FASEB J"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-48.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2051-5960-2-48\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-48","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-48.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T05:51:20Z","timestamp":1648878680000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/2051-5960-2-48"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,24]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["120"],"URL":"https:\/\/doi.org\/10.1186\/2051-5960-2-48","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,24]]},"assertion":[{"value":"20 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"48"}}